Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report

BACKGROUND: Erdheim-Chester disease is a rare histiocytosis characterized by multi-systemic organ involvement. Immune-modulating agents such as interferon-alpha have limited success and the disorder is progressive and causes high morbidity and mortality. Treatment with the BRAF-inhibitor vemurafenib...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Res Notes
Autori principali: Tzoulis, Charalampos, Schwarzlmüller, Thomas, Gjerde, Ivar Otto, Søfteland, Eirik, Neckelmann, Gesche, Biermann, Martin, Haroche, Julien, Straume, Oddbjørn, Vintermyr, Olav Karsten
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4450489/
https://ncbi.nlm.nih.gov/pubmed/25926131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1135-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi